Insmed To Present at the Cowen 42nd Annual Health Care Conference

Rhea-AI Summary

Insmed Incorporated (Nasdaq: INSM) will present at the Cowen 42nd Annual Health Care Conference on March 9, 2022, at 9:10 a.m. ET. The live fireside chat will be accessible via the company's investor relations section on their website, with an archive available for 30 days post-event. Insmed focuses on treating serious and rare diseases and has launched a first-in-disease therapy approved in the U.S., Europe, and Japan. The company is also developing therapies for unmet needs in inflammatory diseases and rare pulmonary disorders.

BRIDGEWATER, N.J., March 3, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Cowen 42^nd Annual Health Care Conference on March 9, 2022 at 9:10 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-cowen-42nd-annual-health-care-conference-301494525.html

SOURCE Insmed Incorporated

FAQ

When is Insmed presenting at the Cowen 42nd Annual Health Care Conference?

Insmed will present on March 9, 2022, at 9:10 a.m. ET.

How can I access Insmed's presentation at the Cowen Conference?

The presentation will be webcast live on Insmed's investor relations website.

What is Insmed's primary focus as a biopharmaceutical company?

Insmed focuses on transforming the lives of patients with serious and rare diseases.

What is Insmed's first commercial product?

Insmed's first commercial product is a therapy approved for chronic lung disease.

Where is Insmed Incorporated headquartered?

Insmed is headquartered in Bridgewater, New Jersey.